X0306 4 2022-02-21 0000064803 CVS HEALTH Corp CVS 0001900910 Shah Prem S ONE CVS DRIVE WOONSOCKET RI 02895 1 EVP and Co-President of Retail Common Stock 2022-02-21 4 A 0 47640 0 A 59620.24 D Common Stock (PSUs) 41463 D Common Stock (restricted) 575 D Common Stock (restricted) 2884 D Common Stock (restricted) 15427 D Common Stock (restricted) 1808 D Common Stock (restricted) 1925 D Common Stock (restricted) 6393 D Common Stock (restricted) 4372.62 D Common Stock (restricted) 2798 D Stock Unit (deferred) 5625.28 D Stock Option 104.82 2017-04-01 2023-04-01 Common Stock 5870 5870 D Stock Option 102.26 2016-04-01 2022-04-01 Common Stock 5346 5346 D Stock Option 62.2011 2019-04-01 2025-04-01 Common Stock 1691 1691 D Stock Option 54.19 2020-04-01 2029-04-01 Common Stock 12626 12626 D Stock Option 58.34 2021-04-01 2030-04-01 Common Stock 34315 34315 D Stock Option 74.30 2022-04-01 2031-04-01 Common Stock 32826 32826 D Stock Option 75.24 2021-08-31 2028-08-31 Common Stock 26580 26580 D Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Consists of remaining Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan (ICP). Restrictions lapse on 02/28/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in two equal installments commencing on 04/01/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in three equal installments commencing on 04/01/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions lapse on 04/01/2022. Consists of remaining RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 ICP. Restrictions lapse in two equal installments commencing on 02/28/2022. Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in four equal installments commencing on 04/01/2022. Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023. Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions lapse in three equal installments commencing on 02/26/2022. Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer. Option becomes exercisable in four equal installments commencing 04/01/2017. Option becomes exercisable in four equal installments commencing 04/01/2016. Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised. Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised. Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised. Option becomes exercisable in three equal installments commencing 04/01/2022. Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023. /s/ Prem S. Shah 2022-02-23